APVO earnings: a positive outcome, +32.8%

On March 24, 2022, Aptevo Therapeutics Inc. reached its earnings. The result was a positive outcome, and the stock moved +32.8% in the window around the event. It had already run -8.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.